These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28319083)

  • 1. Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode.
    Li B; Li H; Lu L; Jiang J
    Nat Struct Mol Biol; 2017 Apr; 24(4):362-369. PubMed ID: 28319083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.
    Rao FV; Schüttelkopf AW; Dorfmueller HC; Ferenbach AT; Navratilova I; van Aalten DM
    Open Biol; 2013 Oct; 3(10):130021. PubMed ID: 24088714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the substrate binding adaptability and specificity of human O-GlcNAcase.
    Li B; Li H; Hu CW; Jiang J
    Nat Commun; 2017 Sep; 8(1):666. PubMed ID: 28939839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into activity and inhibition from the crystal structure of human O-GlcNAcase.
    Elsen NL; Patel SB; Ford RE; Hall DL; Hess F; Kandula H; Kornienko M; Reid J; Selnick H; Shipman JM; Sharma S; Lumb KJ; Soisson SM; Klein DJ
    Nat Chem Biol; 2017 Jun; 13(6):613-615. PubMed ID: 28346407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Inhibitors Targeting Human O-GlcNAcase: Docking-Based Virtual Screening, Biological Evaluation, Structural Modification, and Molecular Dynamics Simulation.
    Dong L; Shen S; Chen W; Xu D; Yang Q; Lu H; Zhang J
    J Chem Inf Model; 2019 Oct; 59(10):4374-4382. PubMed ID: 31487462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
    Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
    Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme molecular mechanism as a starting point to design new inhibitors: a theoretical study of O-GlcNAcase.
    Lameira J; Alves CN; Tuñón I; Martí S; Moliner V
    J Phys Chem B; 2011 May; 115(20):6764-75. PubMed ID: 21542586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine.
    Duan Y; Liu T; Zhou Y; Dou T; Yang Q
    J Biol Chem; 2018 Oct; 293(40):15429-15438. PubMed ID: 30135205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors.
    Shen S; Chen W; Dong L; Yang Q; Lu H; Zhang J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):445-452. PubMed ID: 29390898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.
    Dorfmueller HC; van Aalten DM
    FEBS Lett; 2010 Feb; 584(4):694-700. PubMed ID: 20026047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation.
    Martin JC; Fadda E; Ito K; Woods RJ
    Glycobiology; 2014 Jan; 24(1):85-96. PubMed ID: 24134879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.
    Dorfmueller HC; Borodkin VS; Schimpl M; Shepherd SM; Shpiro NA; van Aalten DM
    J Am Chem Soc; 2006 Dec; 128(51):16484-5. PubMed ID: 17177381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors.
    Kong H; Chen W; Liu T; Lu H; Yang Q; Dong Y; Liang X; Jin S; Zhang J
    Carbohydr Res; 2016 Jun; 429():54-61. PubMed ID: 27233493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
    Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
    EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
    Kim EJ; Perreira M; Thomas CJ; Hanover JA
    J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
    Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
    J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
    Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
    J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.
    Li T; Li Z; Li J; Wang J; Guo L; Wang PG; Zhao W
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6854-7. PubMed ID: 23058883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.
    Hu CW; Worth M; Li H; Jiang J
    Chembiochem; 2019 Feb; 20(3):312-318. PubMed ID: 30199580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase.
    Macauley MS; Vocadlo DJ
    Carbohydr Res; 2009 Jun; 344(9):1079-84. PubMed ID: 19423084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.